Results 191 to 200 of about 85,062 (229)

Analysis of insecticide-treated bednet market dynamics between 2004-2021 and monetary value of additional bednet longevity. [PDF]

Cost Eff Resour Alloc
McCoy A, Thomsen E, Spiers A, Worrall E.
europepmc   +1 more source

Aloe vera–Based Green Synthesis of Silver Nanoparticles With Characterization, Potent Antibacterial and Antioxidant Properties

Asia-Pacific Journal of Chemical Engineering, EarlyView.
ABSTRACT Green synthesis has emerged as a suitable alternative to the traditional method for manufacturing nanoparticles (NPs) as it provides a safer, sustainable, healthy, and environmental path for the NPs synthesis. Silver nanoparticles (AgNPs) were prepared using a green method with locally sourced Aloe vera leaf extract.
Janaki Baral, Sushant Timalsina, Sujan Dhungana, Laxmi Tiwari, Devendra Khadka, Bhoj Raj Poudel   +5 more
wiley   +1 more source

Addressing policy barriers to scaling up needle and syringe programmes: a global call to action.

Lancet Glob Health
Fontaine G, Day E, Luhmann N, Madden A, Sabin K, Scheibe A, Stoove M, Vickerman P, Wisse E, Grebely J, Taylor N, International Network on Health and Hepatitis in Substance Users Policy Day Working Group.   +11 more
europepmc   +1 more source

Microbiological risk assessment during the procurement and processing of cells, tissues and breast milk using the MiRCA tool. [PDF]

Sci Rep
Jandová M, Rudolfová Š, Švorcová M, Měřička P.   +3 more
europepmc   +1 more source

Public interest technology for cancer survivorship in Texas: A survivorship tech bundle. [PDF]

Cancer
Kypriotakis G.
europepmc   +1 more source

The case for ambition: Why countries must move boldly on Near Point-of-Care TB Diagnostics. [PDF]

PLOS Glob Public Health
Lynch S, Mupfumi L, Otieno C, Sharma A, Mataka A.   +4 more
europepmc   +1 more source

Global mechanisms to improve affordability of high-priced medicines: the role of the WHO model lists of essential medicines. [PDF]

J Pharm Policy Pract
Jenei K.
europepmc   +1 more source

Impact of volume-based procurement policy on coronary stent use in tianjin: interrupted time series analysis. [PDF]

J Health Popul Nutr
Yang Z, Ni L, Zhao W, Li Y, Wu Y, Zhu Q, Da L, Liu W, Zhang Q, Li J, Jiang B.   +10 more
europepmc   +1 more source

Addressing challenges along the 'access cascade' for new TB regimens. [PDF]

IJTLD Open
Servello J, de Colombani P, Dall'Olio L, Gargioni G, Raviglione MCB.   +4 more
europepmc   +1 more source